Volume 1 · August 2026
September 2026 A Dual - Awareness Issue Childhood Cancer and Gynecologic & Ovarian Cancer. Childhood Cancer Spotlighting paediatric oncology, early diagnosis, family support, and the resilience of young patients and…
Dr. Kaushik Manisha
In the ever-evolving landscape of cancer care and clinical research, there remains a vital gap between scientific knowledge and the lived experiences of cancer thrivers, caregivers, healthcare professionals, researchers, and…
The white ribbon is the international symbol for lung cancer awareness, worn throughout the year but especially during dedicated awareness months to spotlight prevention, early detection, and support for patients…
Dr. Jeyhan B. Dhabhar · Consultant Medical Oncologist & Hemato-Oncologist, Mumbai, Maharashtra
As oncologists, people often ask us the same question: "How do you deal with so much sadness every day?" The truth is, we don't always have an answer. There are…
Dr. Rukmini Bezbaruah · Associate Professor, Oncopathology · Dr. B. Borooah Cancer Institute, Guwahati, Assam
Lung cancer pathology has moved beyond establishing malignancy to providing the biological information that directly supports treatment selection. A small biopsy must increasingly answer several questions: What is the tumour? What is its histological subtype? Are there actionable molecular alterations? Could the patient benefit from immunotherapy? Molecular profiling may identify actionable alterations such as EGFR, ALK, ROS1, BRAF, KRAS, MET, RET, NTRK and ERBB2, creating opportunities for targeted therapy. PD-L1 assessment provides complementary information for immunotherapy decisions. The pathologist has a pivotal role in converting a limited tissue sample into clinically actionable information.
Dr. Khushboo Rastogi, MBBS, MD, CCEPC (RT for Benign Musculoskeletal Disorders) · Consultant, Radiation Oncology · BLK-MAX Super Specialty Hospital, Delhi
Radiation therapy for lung cancer is evolving beyond simply destroying cancer cells. Stereotactic Body Radiation Therapy (SBRT) delivers a few high-dose treatments directly to the tumour while minimizing damage to nearby healthy tissue, and is the standard for early-stage, inoperable lung cancer. Low-Dose Radiation Therapy (LDRT), by contrast, uses much smaller doses and works by changing the tumour microenvironment — potentially improving blood flow and making immunotherapy work more effectively. This article explains how the two approaches differ and where each may be useful.
Dr. Rutuja G. Vidhale & Dr. Kaushik Jadhav · Bringing Theatre, Reflection, and Human Connection into Healthcare
Healthcare is often described through the language of diagnosis, treatment, recovery, and outcomes. Yet, behind every clinical encounter are human experiences that cannot always be captured in a medical chart…
Jasmohan Kaur · Clinical Oncology Nutritionist, Apollo Hospital, Mumbai
Lung cancer treatment often challenges patients with side effects that compromise nutrition, immunity, and overall well-being. Evidence suggests that overconsumption of calories and obesity significantly increase cancer risk and mortality, while Calorie Restriction with Optimal Nutrition (CRON) may offer protective benefits. Diets emphasizing plant-based antioxidants, phytonutrients, and lean proteins can reduce inflammation, enhance immune function, and aid tissue repair. Maintaining a healthy body weight (BMI < 25) and adopting CRON principles may further lower recurrence risk and improve quality of life — positioning diet as a therapeutic ally in oncology care. Keywords: Optimal Nutrition, Calorie Restriction, Chemotherapy, Lung Cancer
Our Mission The Cancer Lighthouse is a monthly awareness magazine published by Biomes Elements & Research Care Private Limited. Each issue is dedicated to a specific cancer theme, bringing together…